4//SEC Filing
Musso Alan A 4
Accession 0000950170-23-040615
CIK 0001680581other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 4:16 PM ET
Size
5.4 KB
Accession
0000950170-23-040615
Insider Transaction Report
Form 4
Musso Alan A
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2023-08-07+432,800→ 432,800 totalExercise: $4.01Exp: 2033-08-06→ Common Stock (432,800 underlying)
Footnotes (1)
- [F1]This option was granted on August 7, 2023 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of August 7, 2023. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.
Documents
Issuer
Fulcrum Therapeutics, Inc.
CIK 0001680581
Entity typeother
Related Parties
1- filerCIK 0001295830
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 4:16 PM ET
- Size
- 5.4 KB